July 19, 2018

165 A Disruptive Innovation: Gitte Pedersen on Leveraging RNA to Revolutionize Cancer Care with Personalized Treatment

165 A Disruptive Innovation: Gitte Pedersen on Leveraging RNA to Revolutionize Cancer Care with Personalized Treatment

Gitte Pedersen is on a mission to revolutionize cancer treatment. Co-founded of Genomic Expression, Gitte and her brother Morton discovered that different people need different treatments depending on their RNA. Their innovation takes on Big Pharma,...

Apple Podcasts podcast player badge
Spotify podcast player badge
Castro podcast player badge
RSS Feed podcast player badge
Apple Podcasts podcast player iconSpotify podcast player iconCastro podcast player iconRSS Feed podcast player icon

Gitte Pedersen is on a mission to revolutionize cancer treatment. Co-founded of Genomic Expression, Gitte and her brother Morton discovered that different people need different treatments depending on their RNA. Their innovation takes on Big Pharma, which Gitte says wastes $70 billion per year on inffective oncology drugs. She shares her journey as a female entrepreneur, how to eliminate your fears, how to raise venture capital, and what it was like on Sir Richard Branson’s Necker Island.